Calamos Advisors’s InfuSystem Holdings INFU Stock Holding History

Calamos Advisors’s Portfolio INFU Stock Details INFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,628	Closed	-$862K	–	1193
2021 Q4	$862K	Buy	+50,628	New	+$803K	﹤0.01%	1022
2021 Q3	–	Sell	-58,665	Closed	-$1.22M	–	1012
2021 Q2	$1.22M	Sell	58,665 -28,520	-33%	-$577K	0.01%	788
2021 Q1	$1.78M	Buy	+87,185	New	+$1.63M	0.01%	708

Other funds holding INFU

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Calamos Advisors's INFU Position: Q1 2022 in Review

Calamos Advisors sold out of InfuSystem Holdings (INFU) in Q1 2022, closing a stake of 50,628 shares — an estimated $862K sold.

Calamos Advisors first reported a position in INFU in Q1 2021 and held it in 3 quarters. The position peaked at $1.78M in Q1 2021. 78 funds tracked by Wall St. Rank hold INFU as of Q1 2022.

Calamos Advisors reported no remaining InfuSystem Holdings position as of Q1 2022 after selling out during the quarter.
Calamos Advisors sold 50,628 InfuSystem Holdings shares in Q1 2022, an estimated $862K.
Calamos Advisors first reported a position in InfuSystem Holdings in Q1 2021 and held it in 3 quarters.
Calamos Advisors's InfuSystem Holdings position peaked at $1.78M in Q1 2021.
78 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2022.

Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.